The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. The characteristic dynamics of IgG measured using test systems with sorbed whole virion or recombinant spike proteins reflects the duration of the disease.
Article PDF
Similar content being viewed by others
References
Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity. 2020;52(4):583-589. doi: https://doi.org/10.1016/j.immuni.2020.03.007
Bundschuh C, Egger M, Wiesinger K, Gabriel C, Clodi M, Mueller T, Dieplinger B. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma. Clin. Chim. Acta. 2020;509:79-82. doi: https://doi.org/10.1016/j.cca.2020.05.047
Salvatori G, Luberto L, Maffei M, Aurisicchio L, Roscilli G, Palombo F, Marra E. SARS-CoV-2 Spike protein: an optimal immunological target for vaccines. J. Transl. Med. 2020;18(1):222. doi: https://doi.org/10.1186/s12967-020-02392-y
Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 2020;17(6):613-620. doi: https://doi.org/10.1038/s41423-020-0400-4
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARSCoV-2 Spike glycoprotein. Cell. 2020;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058
Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, Zhou Q, Ye H, Ma Y, Li H, Wei X, Cai P, Ma WL. Antibody detection and dynamic characteristics in Patients with COVID-19. Clin. Infect. Dis. 2020;71(8):1930-1934. doi: https://doi.org/10.1093/cid/ciaa461
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody response to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin. Infect. Dis. 2020;71(16):2027-2034. doi: https://doi.org/10.1093/cid/ciaa344
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 2, pp. 196-199, February, 2021
Rights and permissions
About this article
Cite this article
Aleshkin, A.V., Novikova, L.I., Bochkareva, S.S. et al. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection. Bull Exp Biol Med 171, 230–233 (2021). https://doi.org/10.1007/s10517-021-05200-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05200-9